ArticleMolecular pharmaceutics2025

Radiobioconjugate of Kadcyla with Radioactive Gold Nanoparticles for Targeted Therapy of HER2-Overexpressing Cancers.

Kinga Żelechowska-Matysiak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.